Related Experiment Video
Updated: Jun 29, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
[Infection associated with the use of assisted-ventilation devices]
Emili Díaz1, Kenneth Planas, Jordi Rello
1Servicio Medicina Intensiva, Hospital Universitari Joan XXIII, Tarragona, Spain. emilio.diaz.santos@gmail.com
Abstract:
The second most important infectious complication in hospitalised patients is pneumonia, and it hits first place in the Intensive Care Unit (ICU). Almost 80% of the episodes of health-care pneumonia happens when patient is under mechanical ventilation, causing ventilator-associated pneumonia (VAP). VAP is associated with the highest rates of mortality in ICU infections, mainly if due to Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA). It also increases days under mechanical ventilation and the length of stay in ICU and hospital. Although all the diagnostic procedures, the diagnosis of VAP is based basically in the clinics: X-ray infiltrates and purulent endotracheal secretions are the cornerstone of the diagnosis. We should evaluate and screen any risk factor for multiresistant pathogens. If we have an early VAP and no risk factors, the majority of empiric antibiotic strategies are useful, but if we have a patient with more than one week under mechanical ventilation, previous antibiotic use, and risk factors for multiresistant pathogens, we should then individualize empiric antibiotic treatment.
Insights
Ventilator-associated pneumonia (VAP) is a critical ICU infection, often requiring tailored antibiotic strategies for patients with risk factors. Early VAP without risk factors generally responds to standard antibiotics.
Area of Science:
- Critical care medicine
- Infectious diseases
- Pulmonology
Context:
- Pneumonia is the second leading infectious complication in hospitalized patients, ranking first in Intensive Care Units (ICUs).
- Ventilator-associated pneumonia (VAP) accounts for nearly 80% of healthcare-associated pneumonias in mechanically ventilated patients.
- VAP is linked to high mortality rates, particularly when caused by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), and increases ICU/hospital length of stay.
Purpose:
- To highlight the diagnostic challenges and treatment considerations for VAP.
- To emphasize the importance of identifying risk factors for multidrug-resistant pathogens in VAP cases.
- To guide empiric antibiotic selection based on VAP timing and patient risk factors.
Summary:
- VAP diagnosis primarily relies on clinical signs like X-ray infiltrates and purulent secretions.
- Early VAP in patients without specific risk factors typically responds to empiric antibiotic therapy.
- For patients with prolonged mechanical ventilation, prior antibiotic use, or risk factors for multidrug-resistant pathogens, individualized empiric antibiotic treatment is crucial.
Impact:
- Improved VAP management through risk stratification and tailored antibiotic selection.
- Potential reduction in VAP-associated mortality and morbidity.
- Optimized antibiotic use in ICUs, addressing the challenge of multidrug-resistant organisms.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...